The outlook of companies tied to Sildenafil's history presents a challenging investment scenario . While the initial success generated substantial gains, generic competition have significantly impacted revenue. Investing in connected pharmaceutical companies now requires a careful assessment of intellectual property safeguards, evolving patient tre